Market revenue in 2023 | USD 68.3 million |
Market revenue in 2030 | USD 87.8 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.32% in 2023. Horizon Databook has segmented the China in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The IVD quality control market in China is expected to grow at a lucrative rate during the forecast period. This fast growth can be attributed to the high market potential, advancements in healthcare services, and increasing healthcare expenditure.
According to a study published by the UK’s NHS, healthcare expenditure in China is projected to reach USD 25.2 billion by 2027, as the country has one of the largest populations in the world. In addition, the prevalence of chronic conditions, such as cancer, cardiovascular diseases, and infectious diseases, is increasing in China.
These diseases are propelling the demand for improved, technologically advanced, accurate diagnostic tests that can help in the management of these conditions, increasing the need for reliable & accurate laboratory tests. Moreover, key players are undertaking both organic and inorganic growth strategies to gain a competitive edge in China IVD quality control market.
Horizon Databook provides a detailed overview of country-level data and insights on the China in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into China in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account